03.11.2021 Merck KGaA  DE0006599905

DGAP-Adhoc: Merck KGaA raises forecast for full year 2021


 

DGAP-Ad-hoc: Merck KGaA / Key word(s): Change in Forecast/9 Month figures
Merck KGaA raises forecast for full year 2021

03-Nov-2021 / 18:42 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Darmstadt, November 3, 2021. Based on a very strong third quarter of 2021 with net sales of EUR 4.97 bn resulting in EBITDA pre1 of EUR 1.55 bn and EPS pre1 of EUR 2.24, Merck KGaA (the "Company") has further raised its forecast for the entire group for fiscal 2021. The main driver is a very strong operating performance from the Life Science business sector. The Company now projects net sales of approx. EUR 19.30 - 19.85 bn (previously EUR 18.80 - 19.70 bn). EBITDA pre1 is anticipated to grow to approx. EUR 6.0 - 6.3 bn for the group (previously "EUR 5.6 - 6.0 bn"). EPS pre1 is projected to amount to approx. EUR 8.50 - 9.00 (previously "EUR 7.80 - 8.50").
The Company will publish Q3 / 2021 figures as scheduled on 11 November 2021.

1 EBITDA pre and EPS pre are alternative performance measures not defined by international accounting standards, used by the Company to improve the comparability of business performance over time and within the industry. EBITDA pre means earnings before interest, income tax, depreciation and amortization as well as adjustments (Ergebnis vor Zinsen, Ertragsteuern, Abschreibungen und Anpassungen). EPS pre means profit after tax including adjustments per theoretical shares outstanding (see Merck Annual Report 2020).

Andreas Cezanne, Leiter Corporate Media Relations
Merck KGaA
Frankfurter Straße 250
64293 Darmstadt
Deutschland
Email: [email protected]
Internet: www.merck.de
ISIN: DE0006599905
WKN: 659990
Indices: DAX
Stock exchanges: Regulated Market of Frankfurt am Main (Prime Standard); Open Markets of Berlin, Düsseldorf, Hamburg, Hanover, Munich, Stuttgart; EUREX derivatives exchange; London, SIX

03-Nov-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Merck KGaA
Frankfurter Str. 250
64293 Darmstadt
Germany
Phone: +49 (0)6151 72 - 2702
E-mail: [email protected]
Internet: https://www.merckgroup.com/de
ISIN: DE0006599905
WKN: 659990
Indices: DAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; London, SIX
EQS News ID: 1246001

 
End of Announcement DGAP News Service

1246001  03-Nov-2021 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1246001&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2016 2017 2018 2019 2020 2021 2022e
Umsatzerlöse1 15.024,00 15.327,00 14.836,00 16.152,00 17.534,00 19.800,00 0,00
EBITDA1,2 4.415,00 4.282,00 3.528,00 4.066,00 4.923,00 6.260,00 0,00
EBITDA-Marge3 29,39 27,94 23,78 25,17 28,08 31,62 0,00
EBIT1,4 2.481,00 2.525,00 1.727,00 2.120,00 2.985,00 4.070,00 0,00
EBIT-Marge5 16,51 16,47 11,64 13,13 17,02 20,56 0,00
Jahresüberschuss1 1.633,00 2.610,00 3.396,00 1.324,00 1.994,00 3.865,00 0,00
Netto-Marge6 10,87 17,03 22,89 8,20 11,37 19,52 0,00
Cashflow1,7 2.518,00 2.696,00 2.219,00 2.856,00 3.477,00 0,00 0,00
Ergebnis je Aktie8 3,75 5,99 7,76 3,04 4,57 9,10 9,50
Dividende8 1,20 1,25 1,25 1,30 1,40 1,70 2,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2020 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: KPMG

XETR:MRK Charts by TradingView (c)


INVESTOR-INFORMATIONEN
©boersengefluester.de
Merck
WKN Kurs in € Einschätzung Börsenwert in Mio. €
659990 194,600 Kaufen 84.607,78
KGV 2023e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
19,66 24,88 0,77 48,47
KBV KCV KUV EV/EBITDA
4,14 24,33 4,83 20,40
Dividende '20 in € Dividende '21e in € Div.-Rendite '21e
in %
Hauptversammlung
1,40 1,70 0,87 22.04.2022
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
12.05.2022 04.08.2022 11.11.2021 03.03.2022
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-9,09% 5,44% -14,27% 37,77%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Merck KGaA  ISIN: DE0006599905 können Sie bei DGAP abrufen


Gesundheit , 659990 , MRK , XETR:MRK